Home » Authors » Anette Breindl

Articles by Anette Breindl

Peptide Foils Innate Autoimmune Response To Reperfusion Injury

Jan. 20, 2006

By Anette Breindl

Human Bird Flu Data: Less Severe, But More Prevalent

Jan. 17, 2006

By Anette Breindl

Human Bird Flu Data: Less Severe, But More Prevalent

Jan. 17, 2006

By Anette Breindl

Attacking Sickle Cell Anemia With One-Two Genetic Punch

Jan. 12, 2006

By Anette Breindl

Attacking Sickle Cell Anemia With One-Two Genetic Punch

Jan. 12, 2006

By Anette Breindl

How Leukemia Cells Rule Neighbors: With Iron Fist

Jan. 9, 2006

By Anette Breindl

How Leukemia Cells Rule Neighbors: With Iron Fist

Jan. 9, 2006

By Anette Breindl

Study Finds Possibly Better Approach To Cox-2 Inhibition

Jan. 3, 2006

By Anette Breindl

Study Finds Possibly Better Approach To Cox-2 Inhibition

Jan. 3, 2006

By Anette Breindl

Too Much Of Good Gene Raises Tuberculosis Risk

Dec. 30, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 17, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Abbvie and Simcere enter a $1B T-cell engager deal
BioWorld Asia
Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.